COMET™ - High-throughput, hyperplex spatial biology without the need for antibody conjugation скачать в хорошем качестве

COMET™ - High-throughput, hyperplex spatial biology without the need for antibody conjugation

COMET™ is the only fully automated, high-throughput, hyperplex platform ensuring scalability and reproducibility without the need to conjugate primary antibodies: Provides walk-away automation, integrating staining, imaging, and image preprocessing steps to obtain standard hyperplex images. Generates highly robust and reproducible data with full tissue preservation, allowing researchers to perform downstream modalities such as H&E or transcriptomics using the same slide. Its superior tissue profiling capabilities facilitate the analysis of 40 different spatial markers in each automated run on a tissue slide. In contrast to other spatial biology solutions, COMET™ works with off-the-shelf, label-free primary antibodies, making panel design much more flexible and faster than any other hyperplex solution. Works with regular glass slides from standard histology workflows; it is validated for human and mouse samples and is compatible with any other animal sample. The platform can be used for a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology. For further information on Lunaphore and its products, please visit https://lunaphore.com. #SpatialBiology #SpatialProteomics #Lunaphore #SequentialImmunofluorescence #MultiplexedImmunofluorescence #MultiplexedImmunoAssays Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. Connect with Lunaphore online: Website: https://lunaphore.com/ LinkedIn:   / lunaphore   Twitter:   / lunaphore   Facebook:   / lunaphore   Instagram:   / lunaphore